Daniel Cormier and Brock Lesnar got into it at UFC 226
That just happened! @DC_MMA & @BrockLesnar come face-to-face at #UFC226! pic.twitter.com/JZgLC6goC2
— UFC Canada (@UFC_CA) July 8, 2018
Mere minutes after Daniel Cormier’s stirring knockout win over Stipe Miocic to hold the UFC heavyweight championship in addition to his light heavyweight belt, former UFC heavyweight champion and current WWE Superstar Brock Lesnar stormed the Octagon.
Lesnar had arrived at cageside shortly before the fight, fueling rumours of a fight with the Miocic – Cormier winner.
These unfounded thoughts were soon confirmed as “DC” called Lesnar out in his victorious post-fight interview.
“There’s a guy that I’ve known for a long time,” Cormier said in a pro wrestling-style callout. “He’s a wrestler, he’s an All-American, he’s a former UFC champion. I never thought I would fight him, but Brock Lesnar get your ass in here.”
Lesnar didn’t really need an invitation, charging through the Octagon before shoving the newly-crowned double champion.
Lesnar, who is currently the WWE’s Universal Champion, shot a promo of his own – doing more talking than he does in professional wrestling’s squared circle.
“Let me tell you something. I walked into this building and watched the heavyweight disasters from the beginning. [Francis] Ngannou is a piece of s**t. Miocic is a piece of s**t. DC, I’m coming for you motherf**ker!”
UFC President Dana White later confirmed a fight between Cormier and Lesnar is in the works in the post-fight press conference. White also confirmed that Lesnar’s WWE contract allows him to fight for the UFC concurrently.
White said Lesnar re-entered the USADA drug testing pool last week.
Lesnar retired from MMA following his comeback win over Mark Hunt at UFC 200. However, that win was overturned as Lesnar tested positive for a banned performance-enhancing substance.
As Lesnar retired after failing a drug test and is now back in the USADA pool, he will have to serve the six months remaining of his one-year suspension under heavy drug-testing scrutiny.